Clinical Trials in Rehabilitation: Single or Multiple Outcomes?

被引:24
|
作者
Bagiella, Emilia [1 ]
机构
[1] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA
来源
关键词
Clinical trials as topic; Rehabilitation; END-POINTS;
D O I
10.1016/j.apmr.2009.08.133
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Bagiella E. Clinical trials in rehabilitation: single or multiple outcomes? Arch Phys Med Rebabil 2009;90 (11 Suppl 1):S17-21. In clinical trials, the choice of the primary outcome affects the study design, the sample size calculations, the data analysis, and the interpretation of the study results. Most importantly, it may determine the future of the intervention being studied. In several clinical and rehabilitation settings, a single primary outcome measure is often not sufficient to reflect the effect of an intervention because attention is focused on multiple aspects of patients' recovery. In stroke and traumatic brain injuries trials, for example, functional recovery is as important as cognitive recovery. Thus, a trial with a functional scale alone as the primary outcome would not be informative a out the effectiveness of the intervention on cognitive functions. From the methodologic point of view, the choice of multiple primary outcomes presents several challenges, including selecting a measure, among several, to be used for sample size calculations; dealing with multiple comparisons; and interpreting the results. In this article, we discuss a global test procedure that allows investigators to use several binary measures as primary outcomes in a clinical trial. This procedure offers an efficient solution under very reasonable assumptions, avoids loss of power caused by multiple comparisons, has greater statistical power than any single outcome measure, and is easily interpreted and of direct clinical interest.
引用
收藏
页码:S17 / S21
页数:5
相关论文
共 50 条
  • [1] Intermediate outcomes for clinical trials of multiple sclerosis rehabilitation interventions: Conceptual and practical considerations
    Finlayson, Marcia
    Feys, Peter
    Dalgas, Ulrik
    Kos, Daphne
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (09) : 1186 - 1194
  • [2] Recall as a function of single versus multiple trials: Implications for rehabilitation
    Johnstone, B
    Vieth, AZ
    Johnson, JC
    Shaw, JA
    REHABILITATION PSYCHOLOGY, 2000, 45 (01) : 3 - 19
  • [3] Assessment of chronic pain in rehabilitation: Outcomes measures in clinical trials and clinical practice
    Turk, DC
    Burwinkle, TM
    REHABILITATION PSYCHOLOGY, 2005, 50 (01) : 56 - 64
  • [4] BAYESIAN SEQUENTIAL MONITORING DESIGNS FOR SINGLE-ARM CLINICAL-TRIALS WITH MULTIPLE OUTCOMES
    THALL, PF
    SIMON, RM
    ESTEY, EH
    STATISTICS IN MEDICINE, 1995, 14 (04) : 357 - 379
  • [5] BENCHMARKS FOR DESIGNING CLINICAL TRIALS WITH MULTIPLE MORBIDITY OUTCOMES
    Espeland, M.
    Crimmins, E.
    Grossardt, B.
    Harris, T. B.
    Kritchevsky, S.
    Rocca, W.
    Temprosa, M.
    Barzilai, N.
    GERONTOLOGIST, 2016, 56 : 251 - 252
  • [6] Single momentary assessments are not reliable outcomes for clinical trials
    Stone, Arthur A.
    Broderick, Joan E.
    Kaell, Alan T.
    CONTEMPORARY CLINICAL TRIALS, 2010, 31 (05) : 466 - 472
  • [7] Conducting multiple-site clinical trials in medical rehabilitation research
    Fuhrer, MJ
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (11) : 823 - 831
  • [8] Randomized clinical trials in clinical rehabilitation
    Wade, DT
    CLINICAL REHABILITATION, 2005, 19 (03) : 233 - 236
  • [9] Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials
    Sidiqi, M. Hasib
    Al Saleh, Abdullah S.
    Kumar, Shaji K.
    Leung, Nelson
    Jevremovic, Dragan
    Muchtar, Eli
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis V.
    Warsame, Rahma
    Buadi, Francis K.
    Lacy, Martha Q.
    Kyle, Robert A.
    Go, Ronald
    Hobbs, Miriam
    Dispenzieri, Angela
    Dingli, David
    Hayman, Suzanne R.
    Gertz, Morie A.
    Rajkumar, S. Vincent
    Kapoor, Prashant
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : 1131 - 1136
  • [10] Outcomes assessment of drug treatment in multiple sclerosis clinical trials
    Malone, M
    Lomaestro, B
    PHARMACOECONOMICS, 1996, 9 (03) : 198 - 210